Lorence Kim
Interim Chief Operating Officer at Flare Therapeutics · Investor at Ascenta Capital
Investments
4
Lead Investments
3
Highlights
Focus Areas
Biotechnology
Health Care
Pharmaceutical
Therapeutics
Biopharma
Firms Invested Under
Recent Investments